90 related articles for article (PubMed ID: 8630028)
1. Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2.
Scherer SJ; Welter C; Zang KD; Dooley S
Biochem Biophys Res Commun; 1996 Apr; 221(3):722-8. PubMed ID: 8630028
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
3. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
4. The mismatch DNA repair heterodimer, hMSH2/6, regulates BLM helicase.
Yang Q; Zhang R; Wang XW; Linke SP; Sengupta S; Hickson ID; Pedrazzi G; Perrera C; Stagljar I; Littman SJ; Modrich P; Harris CC
Oncogene; 2004 May; 23(21):3749-56. PubMed ID: 15064730
[TBL] [Abstract][Full Text] [Related]
5. Loss of hMSH2 expression in primary breast cancer with p53 alterations.
Spagnoletti I; Pizzi C; Galietta A; Di Maio M; Mastranzo P; Daniele S; Limite G; Pettinato G; Contegiacomo A
Oncol Rep; 2004 Apr; 11(4):845-51. PubMed ID: 15010883
[TBL] [Abstract][Full Text] [Related]
6. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
7. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
8. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
Yang AL; Festing MF
Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells.
Szadkowski M; Iaccarino I; Heinimann K; Marra G; Jiricny J
Cancer Res; 2005 Jun; 65(11):4525-9. PubMed ID: 15930269
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the nucleotide binding domain of the mismatch repair enzyme hMSH-2.
Whitehouse A; Parmar R; Deeble J; Taylor GR; Phillips SE; Meredith DM; Markham AF
Biochem Biophys Res Commun; 1996 Dec; 229(1):147-53. PubMed ID: 8954097
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
Bubb VJ; Curtis LJ; Cunningham C; Dunlop MG; Carothers AD; Morris RG; White S; Bird CC; Wyllie AH
Oncogene; 1996 Jun; 12(12):2641-9. PubMed ID: 8700523
[TBL] [Abstract][Full Text] [Related]
12. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.
Umar A; Koi M; Risinger JI; Glaab WE; Tindall KR; Kolodner RD; Boland CR; Barrett JC; Kunkel TA
Cancer Res; 1997 Sep; 57(18):3949-55. PubMed ID: 9307278
[TBL] [Abstract][Full Text] [Related]
13. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
14. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53.
Shan B; Morris GF
Exp Cell Res; 2005 Apr; 305(1):10-22. PubMed ID: 15777783
[TBL] [Abstract][Full Text] [Related]
15. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
17. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
18. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD
J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of the human mismatch repair gene hMSH2 promoter region.
Scherer SJ; Seib T; Seitz G; Dooley S; Welter C
Hum Genet; 1996 Jan; 97(1):114-6. PubMed ID: 8557250
[TBL] [Abstract][Full Text] [Related]
20. Definition of a consensus binding site for p53.
el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B
Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
